This site requires JavaScript and cookies to be enabled.

Discover an ADHD treatment that helps make symptoms

manageable

Qelbree is a non-stimulant ADHD medication that is an effective and convenient once-a-day treatment for attention-deficit/hyperactivity disorder (ADHD) in children ages 6 to 17 years.

 Results with Qelbree  
 Starting Qelbree  
 Get a savings card  

QUICK QUESTION

Has your child been prescribed any of the following for ADHD?

Thanks for letting us know!

Fun fact: Many patients take Qelbree as their first ADHD medication or switch to Qelbree from other treatments.

See what you can expect from Qelbree 

Qelbree can help control your child’s ADHD symptoms

Reasons to ask your doctor about Qelbree today:

Effective

Qelbree can help significantly reduce ADHD symptoms.

Safe

Qelbree was proven safe* in clinical trials and side effects were manageable when taken as directed.

Convenient

Qelbree can be taken once a day to treat ADHD symptoms.

*Important: Monitor your child for mood or behavior changes. Your child’s doctor should also monitor for changes in blood pressure and heart rate.

“The progress that I’ve made has…been surprising”

It’s been 4 years since Emmett first shared his Qelbree story. Now he’s back, with his mom and family, to share updates.

See Emmett’s latest story  

The questions you want answered.

In clinical trials for patients 6-17 years, the most common side effects were sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability.

Learn more about safety 

Qelbree met the goal of 3 different clinical trials–a significant reduction in ADHD symptom scores in 6 or 8 weeks. For some pediatric patients, Qelbree reduced ADHD symptom scores as early as week 1.

Learn more about efficacy 

Commercially insured patients may pay as little as $20 per prescription.†

Learn more about savings 

†Terms and Conditions apply.

Stay in the know

Join Qelbree Insider to receive Qelbree updates, personalized tips for supporting your child with ADHD, and other helpful resources for you and your child.

Sign up now  

Qelbree® (viloxazine extended-release capsules) Copay Savings Card

Before you head to the pharmacy

Download the Qelbree Savings Card. It’ll help your pharmacist confirm your insurance coverage and avoid unwanted substitutions. That way, refills are smoother going forward. Plus, you could pay as little as $20 per prescription.†

Get your copay card 

†Terms and Conditions apply.

Join the community

When it comes to caring for a child with ADHD, parents and caregivers could use all the support they can get. Check out Qelbree on social for helpful tips, insights, and the chance to connect with other parents in the ADHD community.

What’s the science behind Qelbree?

Learn more  

Back to top  

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.